| scholarly article | Q13442814 |
| P50 | author | Hermann-Josef Gröne | Q29997998 |
| Michael Oellerich | Q47238041 | ||
| Thomas Asendorf | Q90616099 | ||
| Philip D Walson | Q91814334 | ||
| P2093 | author name string | Tim Friede | |
| Julia Beck | |||
| Vedat Schwenger | |||
| Eberhard Wieland | |||
| Maria Shipkova | |||
| Ekkehard Schütz | |||
| Mariana Kabakchiev | |||
| Nina Mettenmeyer | |||
| Verena Schauerte | |||
| Georg Hasche | |||
| P2860 | cites work | Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 |
| Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments | Q30667824 | ||
| Universal noninvasive detection of solid organ transplant rejection | Q34794715 | ||
| Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. | Q35078413 | ||
| Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts | Q35790552 | ||
| A Cost-Benefit Analysis of Government Compensation of Kidney Donors | Q37325891 | ||
| Non-invasive approaches for the diagnosis of acute cardiac allograft rejection. | Q38068995 | ||
| Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options | Q38206175 | ||
| Cell-Free DNA: An Upcoming Biomarker in Transplantation | Q38549101 | ||
| Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients | Q38738318 | ||
| Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury | Q40139338 | ||
| Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation | Q40165772 | ||
| Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study | Q40228674 | ||
| Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study. | Q40779288 | ||
| Interpreting validity indexes for diagnostic tests: an illustration using the Berg balance test | Q44864385 | ||
| Cell-Free DNA and Active Rejection in Kidney Allografts. | Q45971335 | ||
| Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury | Q47839666 | ||
| Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. | Q48005087 | ||
| The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. | Q48112113 | ||
| Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis. | Q52676530 | ||
| American Society of Nephrology Renal Research Report | Q56689285 | ||
| A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology | Q57175415 | ||
| Donor-specific Cell-Free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review | Q57282168 | ||
| Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction | Q57470011 | ||
| Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay | Q60046276 | ||
| Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR | Q61813876 | ||
| Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence | Q82496190 | ||
| Using donor-specific antibodies to monitor the need for immunosuppression | Q84149083 | ||
| A Universal Droplet Digital PCR Approach for Monitoring of Graft Health After Transplantation Using a Preselected SNP Set | Q88538863 | ||
| Subclinical Antibody-mediated Rejection After Kidney Transplantation: Treatment Outcomes | Q90212060 | ||
| P433 | issue | 11 | |
| P921 | main subject | kidney transplantation | Q740909 |
| P304 | page(s) | 3087-3099 | |
| P577 | publication date | 2019-05-28 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study | |
| P478 | volume | 19 |
| Q104794266 | Chronic Active Antibody-Mediated Rejection Following COVID-19 Infection in a Kidney Transplant Recipient: A Case Report |
| Q90411116 | Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study |
| Q92063441 | Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing |
Search more.